Literature DB >> 24720920

Colchicine and the failing heart: a "FINER" anti-inflammatory agent?

Douglas L Mann1.   

Abstract

Entities:  

Keywords:  C-reactive protein; colchicine; heart failure; inflammation; interleukin-6

Mesh：

Substances：

Year:  2014        PMID： 24720920      PMCID： PMC4538941          DOI： 10.1016/j.jchf.2014.02.001

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN： 2213-1779            Impact factor:   12.035


× No keyword cloud information.
  7 in total

1.  Role of microtubules in the contractile dysfunction of hypertrophied myocardium.

Authors:  M R Zile; M Koide; H Sato; Y Ishiguro; C H Conrad; J M Buckley; J P Morgan; G Cooper
Journal:  J Am Coll Cardiol       Date:  1999-01       Impact factor: 24.094

2.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.

Authors:  B Levine; J Kalman; L Mayer; H M Fillit; M Packer
Journal:  N Engl J Med       Date:  1990-07-26       Impact factor: 91.245

3.  The role of microtubules in structural remodeling and the progression to heart failure.

Authors:  Kenneth P Roos; Roy E Palmer; Terrence W Miller
Journal:  J Card Fail       Date:  2002-12       Impact factor: 5.712

4.  Anti-inflammatory treatment with colchicine in stable chronic heart failure: a prospective, randomized study.

Authors:  Spyridon Deftereos; Georgios Giannopoulos; Vasiliki Panagopoulou; Georgios Bouras; Konstantinos Raisakis; Charalampos Kossyvakis; Sofia Karageorgiou; Charalampos Papadimitriou; Maria Vastaki; Andreas Kaoukis; Christos Angelidis; Stamatina Pagoni; Vlasios Pyrgakis; Dimitrios Alexopoulos; Antonis S Manolis; Christodoulos Stefanadis; Michael W Cleman
Journal:  JACC Heart Fail       Date:  2014-04       Impact factor: 12.035

Review 5.  Colchicine and the heart: pushing the envelope.

Authors:  Spyridon Deftereos; Georgios Giannopoulos; Nikolaos Papoutsidakis; Vasiliki Panagopoulou; Charalampos Kossyvakis; Konstantinos Raisakis; Michael W Cleman; Christodoulos Stefanadis
Journal:  J Am Coll Cardiol       Date:  2013-09-11       Impact factor: 24.094

6.  Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

Authors:  Douglas L Mann; John J V McMurray; Milton Packer; Karl Swedberg; Jeffrey S Borer; Wilson S Colucci; Jacques Djian; Helmut Drexler; Arthur Feldman; Lars Kober; Henry Krum; Peter Liu; Markku Nieminen; Luigi Tavazzi; Dirk Jan van Veldhuisen; Anders Waldenstrom; Marshelle Warren; Arne Westheim; Faiez Zannad; Thomas Fleming
Journal:  Circulation       Date:  2004-03-15       Impact factor: 29.690

7.  Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial.

Authors:  Eugene S Chung; Milton Packer; Kim Hung Lo; Adedigbo A Fasanmade; James T Willerson
Journal:  Circulation       Date:  2003-06-09       Impact factor: 29.690
  7 in total
  1 in total

Review 1.  Colchicine for prevention of cardiovascular events.

Authors:  Lars G Hemkens; Hannah Ewald; Viktoria L Gloy; Armon Arpagaus; Kelechi K Olu; Mark Nidorf; Dominik Glinz; Alain J Nordmann; Matthias Briel
Journal:  Cochrane Database Syst Rev       Date:  2016-01-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.